Wuyi International Pharmaceutical (01889) said it reported a loss attributable to owners of Rmb396 million for the year ended 31 December 2016, as compared to the profit of Rmb41.203 million for the previous financial year.
Basic and diluted loss per share was Rmb20 cents.
The revenue was Rmb263 million, a decrease of 52.7% from a year earlier.
Gross profit decreased by 85% to Rmb17.96 million. The gross profit margin recorded a year-on-year decrease of 14.7 percentage points to 6.8%.
No final dividend will be distributed.
Trading in shares of Wuyi International Pharmaceutical will be resumed this morning.
全新節目《說說心理話》原生家庭對成長有咩影響?改善溝通有計可施?► 即睇